Connect with us

News

Sartorius closes 2020 with strong growth to well over 2 billion euros and a further increase in profitability

gbafNews28

GOTTINGEN, Germany, Jan. 27, 2021 /PRNewswire/ — The life science group Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the year with significant double-digit growth rates in sales revenue, order intake1 and earnings, reporting further gains in both divisions and across all geographies.

Sartorius_Logo

“The pandemic year of 2020 was exceptional and very challenging for Sartorius as well. First and foremost, we are glad that we did not have to report any high numbers of infections or serious illnesses among our employees to report. Moreover, in a very intense and demanding environment, we also experienced the strongest year of growth in the company's recent history and were simultaneously able to complete several strategically important acquisitions,” said Executive Board Chairman and CEO Joachim Kreuzburg. “Our strategy and business model proved not only to be particularly resilient in the face of the pandemic. Sartorius has also been contributing directly toward overcoming this pandemic: each and every day, we deliver essential products and technologies to vaccine manufacturers all over the world for producing coronavirus vaccines. Our employees mastered considerable challenges in the past year. A big thank you goes out to the entire international Sartorius team for the fantastic job they did.”

“Looking at the current year and ahead to the future, Kreuzburg remains generally optimistic: “The pandemic is still not over so protecting the health of our employees continues to remain our top priority. In this environment, even short-term forecasts are subject to increased uncertainty. Yet from today's perspective, we expect strong growth for 2021 and beyond. That's why we will accelerate and extend the expansion of our production capacities once again, above all at our sites in Germany, Puerto Rico, and China. Moreover, we considerably raised our mid-term targets for 2025 and now plan to grow our sales to about 5 billion euros.”

Business development of the Group

According to preliminary figures, Group sales revenue surged by 30.2 percent to nearly 2,336 million euros in constant currencies (reported: +27.8 percent). Sartorius thus exceeded its forecast issued at the beginning of the year, which had projected an increase in sales revenue by 10 percent to 13 percent and had been raised during the year. Specifically, this was because of two effects: In addition to strong organic growth, consolidation of the most recent acquisitions contributed a good 7 percentage points to non-organic expansion. Furthermore, the preparations of several biopharmaceutical customers to manufacture coronavirus vaccines and Covid–19 therapeutics also had a positive impact. The influence of these pandemic-related effects on consolidated growth was a good 8 percentage points.

Order intake1 grew even more dynamically than sales revenue and was up 49.0 percent in constant currencies to 2,836 million euros (reported: +46.2 percent). Pandemic-related orders accounted for close to 14 percentage points of growth.

Underlying EBITDA1 also rose very significantly, showing an overproportionate increase in relation to sales revenue, by 39.6 percent to 692 million euros. The respective margin climbed year over year from 27.1 percent to 29.6 percent. Economies of scale in the Bioprocess Solutions Division primarily played a role in this substantial increase in profitability, yet the underproportionate development of costs in some areas as a result of the pandemic also added to this effect, such as the significant reduction of business travel as well as fewer new hires in non-production areas. The most recent acquisitions had a slightly positive effect on the earnings margin, while currency headwinds had a somewhat dilutive impact. Relevant net profit1 for the Group rose in relation to sales, by 42.9 percent to 299 million euros. Underlying earnings per ordinary share were 4.37 euros (previous year: 3.06 euros) and per preference share, 4.38 euros (previous year: 3.07 euros).

Business development of the regions

The Group increased its revenues by double digits in all three geographies yet again. Particularly in the regions of EMEA2 and the Americas, Sartorius benefited from additional demand in connection with the development and manufacture of coronavirus vaccines and Covid-19 therapeutics. Revenue in the Americas, which accounted for about 35 percent of total Group sales, rose sharply, also because of the acquisitions, by 32.8 percent to 812 million euros. Sales revenue in the EMEA2 region that contributed the highest share of around 40 percent to total Group revenue amounted to 935 million euros, up 28.4 percent. Generating around 25 percent of Group sales, the Asia | Pacific region recorded sales revenue totaling 588 million euros, a gain of 29.6 percent. (All figures in sales revenue growth in constant currencies)

Key financial indicators

Sartorius invested substantially in expanding its capacity in 2020 in order to meet high demand. The ratio of capital expenditures (CAPEX) to sales revenue1 remained in the double digits, at 10.3 percent, despite strong sales growth (previous year: 12.3 percent). Equity rose at year-end from 1,093 million euros to 1,402 million euros. The equity ratio of the Group continued to remain at a solid level of 29.9 percent even after closing of the acquisitions and the increased balance sheet total due to a significantly expanded cash position (December 31, 2019:  38.1 percent). Net debt to underlying EBITDA1 increased as expected, from 2.0 at year-end 2019 to 2.6 for the period ended December 31, 2020.

More than 10,600 employees

At the end of 2020, the Group employed 10,637 people worldwide. Compared to the prior-year headcount, this number was thus 1,601 higher. The increase resulted primarily from hiring additional production staff at the company's manufacturing sites with especially high capacity utilization. At the end of the reporting period, around 7,100 people were employed in the EMEA2 region, more than 1,900 in the Americas and about 1,600 in the Asia | Pacific region.

Business development of the divisions

Both divisions contributed significant rates to sales growth. The Bioprocess Solutions Division that offers a wide array of innovative technologies for manufacturing biopharmaceuticals expanded at an exceptionally dynamic rate in the reporting year, with sales up 34.4 percent to 1,783 million euros (reported: +32.0 percent). In addition to strong organic growth across all product categories and geographies, pandemic effects added up to an estimated 12 percentage points of which the majority was attributable to additional sales in connection with the ramp-up of production capacities for coronavirus vaccines and Covid–19 therapeutics. Close to 5 percentage points of the division's growth was due to consolidation of the most recent acquisitions.

Order intake1 developed even more strongly than sales revenue, soaring 56.4 percent in constant currencies (reported: +53.5 percent) to 2,238 million euros, with the pandemic effects described above having a positive impact of around 17 percentage points.

Underlying EBITDA1 of the Bioprocess Solutions Division was 576 million euros, up 46.5 percent very significantly above the prior-year figure of 393 million euros3. Due to economies of scale and pandemic-related underproportionate cost development to some extent, the division's respective margin was up year over year from 29.1 percent3 to 32.3 percent. Currency headwinds had a slightly negative impact, while the most recent acquisitions did not have any significant effect on the division's earnings margin.

The Lab Products & Services Division specializing in equipment and technologies for life science research and pharmaceutical laboratories achieved a sales increase in 2020 of 18.1 percent to 553 million euros (reported: +16.1 percent). Acquisitions contributed about 15 percentage points; the net impact of various countervailing pandemic effects added up to minus 1 percentage point. Thus, the division was confronted in the first half with an extremely challenging economic environment, especially in China and the USA, due to the pandemic. This led to a decline in sales revenue in some product segments. In the second half, rebound and catch-up effects increasingly set in. In particular, demand was high for products such as diagnostic membrane and pipette tips used as part of coronavirus testing. The division's bioanalytics portfolio that includes the protein analytical business acquired from Danaher also grew dynamically. Order intake rose even more strongly than sales revenue, climbing 26.4 percent (reported: +24.1 percent) to 598 million euros.

Underlying EBITDA1 for the Lab Products & Services Division rose by 13.2 percent from 103 million euros3 a year earlier to 116 million euros in the reporting year; the corresponding margin reached 21.0 percent relative to 21.6 percent3 in the previous year. The main reason for the slight decline was the weaker capacity utilization at some plants in the first half of the year due to the pandemic, while the most recent acquisitions had a positive impact of a good 2 percentage points on the division's margin. Exchange rates did not have any significant effect on the division's earnings margin.

Forecast for 2021

Sartorius plans to grow profitably in 2021 as well. Consolidated sales revenue is thus projected to increase by about 19 percent to 25 percent. Initial consolidation of the acquisitions is expected to contribute about 5.5 percentage points to this growth, and the impact of the pandemic-related businesses on Group revenue is difficult to estimate at the present time and is likely to amount to up to 6 percentage points. Regarding profitability, the company forecasts that its underlying EBITDA1 margin will be about 30.5 percent, up from 29.6 percent a year earlier. Due to dynamic organic growth, Sartorius is extending and accelerating the expansion of production capacities and its digital infrastructure. As a result, the CAPEX ratio is expected to be around 15 percent (previous year: 10.3 percent).

For the Bioprocess Solutions Division, the Executive Board expects sales to grow between 22 percent and 28 percent, with consolidation of the most recent acquisitions likely to contribute about 6 percentage points and the pandemic effects up to 8 percentage points. For the division's underlying EBITDA1 margin, management forecasts a moderate increase to around 33 percent (previous year: 32.3 percent) after the underproportionate cost development as a result of the pandemic had additionally increased this margin in the prior year, especially in this division, and now that corresponding effects resulting from pent-up demand are included in this projection.

The Lab Products & Services Division is projected to increase its sales revenue by 10 percent to 16 percent, with the most recent acquisitions expected to contribute around 5 percentage points to growth. Pandemic effects are not anticipated unless laboratories will be closed again as part of potentially very extensive lockdowns. For the division's underlying EBITDA1 margin, a substantial increase to about 23.0 percent is forecasted (previous year: 21.0 percent).

All forecasts are based on constant currencies, as in the past years. In addition, the company assumes that the global economy will increasingly recover as the current year progresses and that supply chains will remain stable.

Mid-term targets up to 2025 updated

As early as 2018, management presented its strategy and long-term targets for the period of 2020 to 2025. The targets for 2025 have now been updated and partly raised, given the results achieved in the Bioprocess Solutions Division in 2020 and the resulting increase in the baseline values, as well as expectations of future organic growth in this segment.

Accordingly, Sartorius now plans to increase its consolidated sales revenue to about 5 billion euros in the five-year period up to 2025 (previous target: around 4 billion euros). The company intends to achieve this increase in both divisions primarily through organic growth as well as additionally by acquisitions. The Group's underlying EBITDA1 margin is forecasted to rise to around 32 percent (former guidance: around 28 percent). For the Bioprocess Solutions Division, the company now projects sales revenue of around 3.8 billion euros (former guidance: approximately 2.8 billion euros), with an underlying EBITDA1 margin of around 34 percent (former guidance: around 30 percent). The outlook for the Lab Products & Services Division remains unchanged, with sales revenue forecasted at around 1.2 billion euros and an underlying EBITDA1 margin at about 25 percent.

These projections are based on the assumption that on average the margins of future acquisitions will initially be somewhat below and, after integration, at a level comparable to those of the Group's existing businesses, and that there will be no relevant changes in the key currency exchange rates.

Management points out that the dynamics and volatilities in the life science and biopharma sectors have increased over the past years and the coronavirus pandemic has further amplified this trend, so that multi-year forecasts show even higher uncertainties than usual.

  1. Sartorius publishes alternative performance measures that are not defined by international accounting standards. These are determined with the aim of improving the comparability of business performance over time and within the industry.
    •  Order intake: all customer orders contractually concluded and booked during the respective reporting period
    •  Relevant / underlying EBITDA: earnings before interest, taxes, depreciation and amortization and adjusted for extraordinary items
    •  Relevant net profit: profit for the period after non-controlling interest, adjusted for extraordinary items and non-cash amortization, as well as based on the normalized financial result and the normalized tax rate
    •  Ratio of net debt to underlying EBITDA: quotient of net debt and underlying EBITDA over the past 12 months, including the pro forma amount contributed by acquisitions for this period
    •  CAPEX ratio: investment payments in relation to sales revenue for the same period
  2. EMEA = Europe, Middle East, Africa
  3. Sales revenues and margins of the divisions in the comparable period adjusted to reflect the reallocation of two small product segments

This press release contains forward-looking statements about the future development of the Sartorius Group. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius assumes no liability for updating such statements in light of new information or future events. This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version.

Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.

Conference call

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius, and Rainer Lehmann, Executive Board member and CFO, will discuss the company's business results with analysts and investors on January 27, 2021, at 3:30 p.m. Central European Time (CET) in a teleconference. You may register by clicking on the following link:
https://78449.choruscall.com/dataconf/productusers/sar/mediaframe/42744/indexl.html

The presentation will be available on the same day starting at 2:30 p.m. CET, for viewing on our website at:
https://www.sartorius.com/en/company/investor-relations/sartorius-ag

Current image files
https://www.sartorius.com/en/company/newsroom/downloads-publications

Financial calendar

February 18, 2021               Publication of Annual Report 2020
March 26, 2021                   Virtual Annual Shareholders' Meeting
April 21, 2021                      Publication of first-quarter figures (January to March 2021) 
July 21, 2021                       Publication of the first-half figures (January to June 2021)
October 20, 2021                Publication of nine-month figures (January to September 2021)

 

Preliminary key performance indicators for fiscal 2020

Sartorius Group

 Bioprocess Solutions1

Lab Products & Services1

In millions of €, unless otherwise specified

2020

2019

Δ in % Reported 

Δ in % cc2

2020

2019

Δ in % Reported

Δ in % cc2

2020

2019

Δ in % Reported

Δ in % cc2

Sales Revenue and Order Intake

Order intake

2,836.3

1,939.5

46.2

49.0

2,238.1

1,457.6

53.5

56.4

598.2

481.9

24.1

26.4

Sales revenue

2,335.7

1,827.0

27.8

30.2

1,782.6

1,350.5

32.0

34.4

553.0

476.5

16.1

18.1

 –  EMEA3

935.1

733.4

27.5

28.4

698,5

524.8

33.1

33.8

236.6

208.6

13.4

14.7

 –  Americas3

812.2

629.9

28.9

32.8

651.3

501.1

30.0

33.7

160.9

128.7

25.0

29.1

 –  Asia | Pacific3

588.4

463.7

26.9

29.6

432.9

324.5

33.4

36.5

155.5

139.2

11.7

13.4

Earnings

EBITDA4

692.2

495.8

39.6

575.9

393.1

46.5

116.3

102.7

13.2

EBITDA margin4 in %

29.6

27.1

32.3

29.1

21.0

21.6

Net profit for the period5

299.3

209.4

42.9

Financial Data per Share

Earnings per ordinary share5 in €

4.37

3.06

43.0

Earnings per preference share5 in €

4.38

3.07

42.9

 

1 Sales revenues and margins of the divisions in the comparable period adjusted to reflect the reallocation of two small product segments

2 In constant currencies abbreviated as “cc”

3 Acc. to the customer's location

4 Relevant / underlying EBITDA: earnings before interest, taxes, depreciation and amortization and adjusted for extraordinary items

5 After non-controlling interest, adjusted for extraordinary items and non-cash amortization, as well as based on the normalized financial result and the normalized tax rate

A profile of Sartorius

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros according to its preliminary figures. At the end of 2020, nearly 11,000 people were employed at the Group's approximately 60 manufacturing and sales sites, serving customers around the globe. https://www.sartorius.com/en

Contact:
Petra Kirchhoff    
Head of Corporate Communications
+49 (0)551 308 1686
[email protected]    

Cision View original content:https://www.prnewswire.com/news-releases/sartorius-closes-2020-with-strong-growth-to-well-over-2-billion-euros-and-a-further-increase-in-profitability-301215854.html

SOURCE Sartorius AG

News

Arlo Launches New Battery-Powered, Wire-Free Essential Video Doorbell In Singapore

gbafNews28

Industry-Leading 180-Degree Field-of-View with Square 1:1 Aspect Ratio Delivers Most Complete Front-Entry Protection, With Direct-to-Mobile Video Calls for Faster Response

 

SINGAPORE – Media OutReach – 16
February 2021 – Arlo Technologies, Inc. (NYSE:
ARLO), one of the leading internet-connected camera brands, today announced the launch of
its all-new Arlo Essential Video Doorbell Wire-Free which brings the award-winning features of
its popular Wired Video Doorbell to an easy-to-install, wire-free,
battery-powered design. Arlo’s latest front-entry solution — which joins a
robust ecosystem of home security products and services — captures what conventional
video doorbells can’t. An industry-leading, 180-degree viewing angle with a square,
1:1 aspect ratio ensures users can see packages on the ground or visitors from
head-to-toe on their mobile devices. HD video resolution combined with
direct-to-mobile video calls, clear, two-way audio and personalised alerts, allow
users to quickly reply to guests or take action. Able to connect directly to
WiFi, the latest solution can be powered by its rechargeable battery1
or be hardwired for continuous charging2. With a RRP of S$329, the Arlo
Essential Video Doorbell Wire-Free is now available at
major retailers including Harvey Norman, Challenger as well
as the official Arlo stores on Lazada
Singapore
and
Shopee
Singapore
.

 

“In today’s world, having a smart video
doorbell at your front door is more valuable than ever,” said Brad Little, Vice President & Managing Director
APAC. “Unlike other video doorbells that
can lag in response time, our new Essential Video Doorbell Wire-Free leverages
the latest hardware and software advancements for swift, comprehensive
monitoring. Industry-leading picture and audio quality combined with our
AI-based subscription service, Arlo Smart, enable complete front door
protection. Users can receive smart notifications and secure, simple access via
the Arlo App, allowing them to quickly and easily live stream or respond to
guests.”

 

Direct-to-mobile video calls, clear, two-way
audio and pre-recorded quick-reply messages all enable convenient, in-the-moment
communication with visitors. Traditionally, video doorbells require users to
take multiple steps to view and respond to guests once receiving a
notification, causing delays where a user could easily miss their visitor. The Arlo
Essential Video Doorbell Wire-Free solves this problem by sending a live, HD
video call right to the user’s smartphone once the doorbell is pressed,
enabling them to quickly take action by deploying a response.

 

Features of the all-new Arlo Essential Video
Doorbell Wire-Free include:

 

  • 180°
    Viewing Angle:
    Optimised for the
    front door with a 1:1 aspect ratio so you can see a person from head to toe or
    a package on the ground
  • Direct-to-Mobile
    Video Call:
    Calls your phone
    directly so you never miss a visitor
  • Multiple
    Powering Options
    : Install without
    wires using the rechargeable battery1, or hardwire to existing
    wiring for continuous charging2
  • Motion
    Detection and Alerts:
    Receive
    alerts when motion is detected
  • Angle
    Mount:
    Easily adjust viewing
    angle to fully and clearly see visitors
  • 2-Way
    Audio:
    Hear what matters with clear,
    noise-cancelling audio
  • More Ways to Answer: Quick Reply Messages enable
    users to play pre-recorded messages for instant response to guests
  • Visitor
    Messaging:
    Guests can leave
    you a voice message if you’re unable to answer the door, and you can listen
    remotely at your convenience
  • HD
    Video with HDR:
    Capture vivid
    detail in bright and dark areas with HDR
  • Night
    Vision:
    See who’s at your door
    at night, even without a light on
  • Weather
    Resistant:
    Designed to
    withstand heat, cold, rain or sun
  • Platform
    Compatibility:
    Works with Alexa,
    Google Assistant and IFTTT for easy interaction, automation, and control
  • Direct
    to WiFi
    : Connects directly to
    WiFi for simple setup allowing it to function as a standalone home security solution without the need for a separate
    base station
  • Built-In
    Smart Siren:
    Trigger your
    siren automatically or manually from the Arlo app during an event
  • Silent
    Mode:
    Temporarily disable
    incoming calls, Arlo Chime melodies, and/or traditional chime rings
  • Notifications
    that Matter:
    Get alerts when
    your Essential Video Doorbell Wire-Free spots people, vehicles, animals or a
    package with Arlo Smart via an included three-month trial with rolling 30-day
    cloud recordings

 

The purchase of an Arlo Essential Video
Doorbell Wire-Free unlocks a complimentary three-month trial to Arlo’s AI subscription-based
service, Arlo Smart. Users will receive access to 30-days of rolling HD video
recordings to store and view video clips. Notification settings can be
adjusted, enabling Arlo Smart subscribers to fully customise their experience
to spot people, vehicles, animals or packages3. Controlled entirely through
the Arlo app, users can easily view live streams and recordings, adjust their
camera settings or access cloud recordings.

 

For more information on the full range of Arlo smart home security products and services, visit https://www.arlo.com/asia/.

1 Rechargeable battery lasts from three to
six months on one charge

2 If choosing to hardwire, users will need
existing electrical/doorbell wiring with voltage between 8V AC and 24V AC

3 Personalised
alerts made available through the complimentary three-month Arlo Smart trial
subscription

About Arlo Technologies, Inc.

Arlo is the award-winning, industry leader that is transforming the way people experience the connected lifestyle. Arlo’s deep expertise in product design, wireless connectivity, cloud infrastructure and cutting-edge AI capabilities focuses on delivering a seamless, smart home experience for Arlo users that is easy to setup and interact with every day. The company’s cloud-based platform provides users with visibility, insight and a powerful means to help protect and connect in real-time with the people and things that matter most, from any location with a Wi-Fi or a mobile connection. To date, Arlo has launched several categories of award-winning smart connected devices, including wire-free smart Wi-Fi and 4G-enabled security cameras, audio and video doorbells, and floodlight.  

 

With a mission to bring users peace of mind, Arlo is as passionate about protecting user privacy as it is about safeguarding homes and families. Arlo is committed to supporting industry standards for data protection designed to keep users’ personal information private and in their control. Arlo doesn’t monetise personal data, provides enhanced controls for user data, supports privacy legislation, keeps user data safely secure, and puts security at the forefront of company culture.

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The words “anticipate,” “expect,” “believe,” “will,” “may,” “should,” “estimate,” “project,” “outlook,” “forecast” or other similar words are used to identify such forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. The forward-looking statements represent Arlo Technologies, Inc.’s expectations or beliefs concerning future events based on information available at the time such statements were made and include statements regarding: Arlo Essential Video Doorbell Wire-Free, Arlo Smart, and future Arlo products. These statements are based on management’s current expectations and are subject to certain risks and uncertainties, including the following: future demand for the Company’s products may be lower than anticipated; consumers may choose not to adopt the Company’s new product offerings or adopt competing products; and product performance may be adversely affected by real world operating conditions. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Therefore, actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. Further information on potential risk factors that could affect Arlo and its business are detailed in the Company’s periodic filings with the Securities and Exchange Commission, including, but not limited to, those risk factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Given these circumstances, you should not place undue reliance on these forward-looking statements. Arlo undertakes no obligation to release publicly any revisions to any forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Continue Reading

News

Knowledgehook to boost maths attainment across Australia

gbafNews28

Knowledge aims to accelerate recent improvements in math attainment levels, across all age groups, in Australia. The Learner First to distribute Knowledgehook technology across Australia.

 

CANBERRA, AUSTRALIA – News Direct – 16
February 2021 – Knowledgehook, the
world’s most comprehensive mathematics learning platform, has launched in
Australia as the nation’s teachers turn a corner in addressing low maths
attainment levels for young people. It is now available to schools across the
country for children in Year 3 to Year 10 classes, through The Learner First, a
consultancy working with schools across Australia.

 

The latest TIMSS (Trends in
International Mathematics and Science Study) found that Australia’s achievement
in mathematics has improved since 2015. However, Year 4 mathematics achievement
has not changed since 2007. One of the biggest challenges facing educators is
to find better ways to meet the learning needs of the many students who fall
behind in schools, failing to meet year-level expectations (often year after
year) and, as a consequence, become increasingly disengaged.

 

Knowledgehook’s proprietary technology
harnesses the power of data to track where students are on their math journey.
Their programmes connect a child’s at-home learning with in-school education,
providing real-time insights to teachers on learning gaps. This empowers
teachers to develop an understanding of the maths concepts related to their
students’ challenges, enabling them to adjust instruction and monitor student
progress.

Knowledgehook: The Instructional Guidance System for
teachers

 

As Knowledgehook launches across
Australia, former Australian Mathematics
Curriculum leader, Margaret Bigelow
, commented: “Australia’s results
in international testing are improving. The impact of a national approach to
teaching and learning Mathematics has impacted on this improved outcome.
Teachers need to be supported to maintain this trajectory of improvement by
having the ideas and tools to enhance the engagement of their students to
develop critical and creative thinking and further mathematical skills. This will
enable students to adjust to the ever-changing demands and challenges of life
in the future.”

 

“Knowledgehook was inspired by my own
struggle with maths as a child,” explained CoFounder and CEO of Knowledgehook, Travis Ratnam. “Having the
right, personalised guidance makes all the difference and every student
deserves to have a teacher who has access to the best pedagogical tools, and
parents who have insights into their learning. Our platform is not a game, it
pulls together a 360 view on a child’s learning journey enabling people around
them to improve the child’s math experience and outcomes.

Knowledgehook founders: (L to R) Travis Ratnam and Qamar
Qureshi

 

In launching Knowledgehook across
Australia, Joanne McEachen, Founder and
CEO of The Learner First
commented: “I love the fact maths support is
available 24/7 so when a learner struggles with a math’s concept, the teacher
can access professional learning and development to help support both the
learner and the teacher on the spot. Moreover, it helps teachers retrace their
approach and identifies what may have been missed allowing them to recover and
embed essential skills and concepts. Quite simply, it is what we have been
missing for years and it will certainly complement the current trajectory of
further improving math’s performance and disposition in Australian students.”

 

Knowledgehook’s AI-enabled platform has
grown to support schools across the US, Mexico, and the UK. It is designed to
scale across multiple countries and languages developing teacher capacity while
engaging students and providing actionable insights for parents. Over the
years, Knowledgehook’s research-based solution has garnered industryleading
partnerships and investments from the most recognised global education bodies,
notably from the University College of London (UCL), the global leader in
education research.

 

Knowledgehook actively collaborates with
governments around the world while also working directly with schools and their
suppliers, to offer curriculum-aligned solutions. The company currently
empowers teachers in more than 100,000 schools. In 2021, it is anticipated the
solution will reach 50,000,000 students globally. “We have received growing
interest for our technology and expertise to be applied to other subjects and
we look forward to expanding our solution to empower more educators and support
the learning of students to become the problem-solvers of tomorrow,” Qamar Qureshi, President and Chief Business
Officer
added.

 

About Knowledgehook

Knowledgehook, a leading educational technology company, empowers hundreds of thousands of teachers and parents to collaboratively support the mathematics learning journey of millions of students worldwide.

 

Winner of Google’s Game Changer Award and named Top Disruptor by BNN, its platform analyses student understanding through engaging assessments, providing real-time personalised solutions to close learning gaps between classroom teaching and at-home learning.

 

Designed by leading numeracy and research experts, Knowledgehook’s Instructional Guidance System is known for reinventing how online technology supports education and educators, while inspiring the problem solvers of tomorrow.

Continue Reading

News

DHL delivers COVID-19 vaccines to Japan

gbafNews28

Rigorous planning and testing to ensure supply chain supports vaccine’s stringent temperature requirements

 

TOKYO, JAPAN  Media OutReach – 16 February 2021  DHL, the
leading global brand in the logistics industry today announced the successful
delivery of the first shipment of COVID-19 vaccines on a cargo flight from
Belgium to Japan. The first of numerous shipments that will be delivered
throughout the year, the vaccines were packed with sophisticated GPS and
temperature trackers in each thermal shipper box to provide full visibility
throughout the shipment’s entire journey. DHL Global Forwarding also handled
the customs clearance in Japan, and will dispatch the vaccines to vaccination
facilities across Japan.


“We are proud to play a role in helping the people of Japan
receive their vaccinations for COVID-19, which has upended lives and businesses
here. While DHL Global Forwarding’s well-established cold-chain network and
pharmaceutical logistics expertise were key to the success of the shipment, our
dedicated employees were the true unsung heroes who meticulously planned every
last detail to manage an extremely complex operation seamlessly,” said Kelvin
Leung, CEO DHL Global Forwarding Asia Pacific.


To safely store the
vaccines at -70 degrees until the final domestic delivery, freezers were
installed at the storage facility, where additional workers have been employed
to support the operations.

 

Charles Kaufmann, CEO, North Asia & South Pacific, DHL
Global Forwarding and President/ Representative Director, DHL Global Forwarding
Japan K.K. added, “We have more than 9,000 life science and healthcare specialists
across our global network. Over the past few months,
our specialist teams in Japan, together with our global
counterparts have spent countless hours
planning,
strategizing and stress-testing our network and infrastructure
to ensure we have the capability to move vaccines safely in
accordance with the strictest requirements.” 

 

Across the globe, DHL has been entrusted with the shipments
of COVID-19 vaccines to
Singapore, Israel, and European
countries
including Austria, Bulgaria, Croatia, Greece, Finland,
Italy, Lithuania, Norway, Romania and Sweden.

 

DHL’s portfolio for the life
science and healthcare industry includes 150+ pharmacists, 20+ clinical trials
depots, 100+ certified stations, 160+ GDP-qualified warehouses, 15+
GMP-certified sites, 135+ medical express sites, and a time-definite
international express network covering 220 countries and territories.



Globally, logistics providers are challenged to establish medical supply chains rapidly to deliver vaccines of
unprecedented amount of more than 10 billion doses worldwide, including in
regions with less developed logistics infrastructure
, where
approximately three billion people live. To provide global coverage over the next two years, DHL estimated in
its vaccine
whitepaper report that up to 200,000 pallet shippers and 15 million
cooling boxes as well as 15,000 flights will be required
across the
various supply chain setups.

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 380,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as “The logistics company for the world”.

 

DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 63 billion euros in 2019. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. Deutsche Post DHL Group aims to achieve zero-emissions logistics by 2050.

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call for Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Posts

gbafNews28 gbafNews28
News17 mins ago

Henkel unveils upgraded Innovation and Application Lab in Sydney

New facility targets growth sectors in Australia and New Zealand   SYDNEY, AUSTRALIA – Media OutReach – 17 February 2021 – Henkel Australia has...

gbafNews28 gbafNews28
News17 mins ago

Indonesia’s E-grocery Industry Poised to Hit USD 6B GMV by 2025

JAKARTA, INDONESIA – Media OutReach – 16 February 2021 – According to L.E.K. Consulting‘s latest insights, Indonesia’s e-groceries market is nearing a...

gbafNews28 gbafNews28
News17 mins ago

Dachser Air & Sea Logistics reorganizes regional management

Dr. Tobias Burger to head the ASL EMEA business unit, Ralph Riehl to take over the ASL Americas business unit...

gbafNews28 gbafNews28
News17 mins ago

Steinhoff International Holdings N.V.: Notice of the Availability of A s155 Proposal

AMSTERDAM, THE NETHERLANDS – EQS Newswire – 16 February 2021 – Notice is hereby given to inter alia certain creditors (“Scheme Creditors“) of...

gbafNews28 gbafNews28
News17 mins ago

65% of Companies in Thailand to Maintain or Increase Employment Headcount in 2021: Survey

BANGKOK, THAILAND – Media OutReach – 16 February 2021 – Professional recruitment services Michael Page Thailand launched the Talent Trends 2021 Report, with...

gbafNews28 gbafNews28
News17 mins ago

DHL delivers COVID-19 vaccines to Japan

Rigorous planning and testing to ensure supply chain supports vaccine’s stringent temperature requirements   TOKYO, JAPAN – Media OutReach – 16 February 2021 – DHL, the...

gbafNews28 gbafNews28
News17 mins ago

Knowledgehook to boost maths attainment across Australia

Knowledge aims to accelerate recent improvements in math attainment levels, across all age groups, in Australia. The Learner First to...

gbafNews28 gbafNews28
News17 mins ago

Arlo Launches New Battery-Powered, Wire-Free Essential Video Doorbell In Singapore

Industry-Leading 180-Degree Field-of-View with Square 1:1 Aspect Ratio Delivers Most Complete Front-Entry Protection, With Direct-to-Mobile Video Calls for Faster Response...

gbafNews28 gbafNews28
News17 mins ago

South Korean Startup bitsensing Partners with Infineon Technologies to Introduce Innovative In-Cabin Sensing Solution

The MOD620 Combines bitsensing’s Groundbreaking Radar Technology with Infineon’s Industry Leading Chipsets   SEOUL, KOREA – Media OutReach – 16 February 2021 – Today, bitsensing, a...

gbafNews28 gbafNews28
News17 mins ago

Hong Kong Productivity Council and Hong Kong Computer Society Sign Pact to Enhance the Adoption of Emerging Technologies in Hong Kong

HONG KONG SAR – Media OutReach – 22 February 2021 – The Hong Kong Productivity Council (HKPC) and the Hong Kong Computer Society (HKCS)...